| Filed On | Filing |
|---|---|
| 18 Jun 2024 |
Form 3: Fraser Nicola Marion, Director
No securities owned |
| 01 Jun 2023 |
Form 3: Ma-Ran Foundation, 10% owner
Holds 213,265 shares of Common stock, par value $0.01 per share |
| 01 Jun 2023 |
Form 3: Gary W. Rollins Foundation, 10% owner
Holds 190,489 shares of Common stock, par value $0.01 per share |
| 17 Oct 2022 |
Form 3: Jenkins David A, Director
No securities owned |
| 14 Oct 2022 |
Form 3: Isenberg Jason, Director
No securities owned |
| 30 Dec 2020 |
Form 3: Kempler Leonard Victor, Director
Holds 2,450 shares of Common stock, par value $0.01 per share |
| 30 Dec 2020 |
Form 3: Margelis George, Director
No securities owned |
| 30 Dec 2020 |
Form 3: Towers Christopher, Director
No securities owned |
| 30 Dec 2020 |
Form 3: Sakiris Spiro Kevin, Chief Financial Officer
Holds 300 shares of Common stock, par value $0.01 per share |
| 30 Dec 2020 |
Form 3: Sessler Jonathan Lawrence, Director
No securities owned |
| 30 Dec 2020 |
Form 3: Life Science Biosensor Diagnostics Pty Ltd, 10% owner
Holds 5,747,647 shares of Common Stock |
| 30 Dec 2020 |
Form 3: Hurd Jonathan Scott, Director
No securities owned |
| 30 Dec 2020 |
Form 3: Simeonidis Harry, Director
Holds 600 shares of Common stock, par value $0.01 per share |
| 30 Dec 2020 |
Form 3: Gavrilenko Victoria, Director
No securities owned |
| 30 Dec 2020 |
Form 3: Parmakellis Tom, Director
No securities owned |
| 30 Dec 2020 |
Form 3: Boyages Steven Constantine, Director
No securities owned |
| 30 Dec 2020 |
Form 3: Fisher Lawrence B, Director
No securities owned |
Loading...